Valsartan Krka Filmuhúðuð tafla 160 mg Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan krka filmuhúðuð tafla 160 mg

krka sverige ab - valsartanum inn - filmuhúðuð tafla - 160 mg

Valsartan Jubilant Filmuhúðuð tafla 80 mg Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan jubilant filmuhúðuð tafla 80 mg

jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 80 mg

Enalapril Krka Tafla 2,5 mg Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

enalapril krka tafla 2,5 mg

krka sverige ab - enalaprilum maleat - tafla - 2,5 mg

Valpress Filmuhúðuð tafla 160 mg Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

valpress filmuhúðuð tafla 160 mg

teva b.v.* - valsartanum inn - filmuhúðuð tafla - 160 mg

Valpress Filmuhúðuð tafla 80 mg Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

valpress filmuhúðuð tafla 80 mg

teva b.v.* - valsartanum inn - filmuhúðuð tafla - 80 mg

Valsartan Jubilant Filmuhúðuð tafla 160 mg Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan jubilant filmuhúðuð tafla 160 mg

jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 160 mg

Valsartan Krka Filmuhúðuð tafla 80 mg Islanda - Iżlandiż - LYFJASTOFNUN (Icelandic Medicines Agency)

valsartan krka filmuhúðuð tafla 80 mg

krka sverige ab - valsartanum inn - filmuhúðuð tafla - 80 mg

Akeega Unjoni Ewropea - Iżlandiż - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - stækkun Æxli, gelding-Þola - Æxlishemjandi lyf - treatment of adult patients with prostate cancer.

Daklinza Unjoni Ewropea - Iżlandiż - EMA (European Medicines Agency)

daklinza

bristol-myers squibb pharma eeig - daclatasvir díhýdróklóríð - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - daklinza er ætlað í samsettri meðferð með öðrum lyfjum til meðferðar við langvinna lifrarbólgu c veiru (hcv) sýkingu hjá fullorðnum (sjá kafla 4. 2, 4. 4 og 5. fyrir hcv arfgerð sérstakur starfsemi, sjáðu kafla 4. 4 og 5.

Entresto Unjoni Ewropea - Iżlandiż - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjartabilun - ace ii hemla, önnur sturtu, umboðsmenn starfa á renín-ace kerfi - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.